During the past decade, Specijalna Bolnica za Reumatske bolesti Novi Sad conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Specijalna Bolnica za Reumatske bolesti Novi Sad" are "Rheumatoid Arthritis" (1 trials), "Vitamin D Deficiency" (1 trials) and "Vitamin D Insufficiency" (1 trials). Many other conditions were trialed in "Specijalna Bolnica za Reumatske bolesti Novi Sad" in a lesser frequency.

Most popular intervention types in "Specijalna Bolnica za Reumatske bolesti Novi Sad" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Calcifediol 100mcg" (1 trials), "Calcifediol 125mcg" (1 trials), "Calcifediol 75mcg" (1 trials), "EU-approved RoActemra" (1 trials) and "MSB11456" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specijalna Bolnica za Reumatske bolesti Novi Sad" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Specijalna Bolnica za Reumatske bolesti Novi Sad". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Specijalna Bolnica za Reumatske bolesti Novi Sad, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Specijalna Bolnica za Reumatske bolesti Novi Sad, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".